Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder. Stein MD, Anderson BJ, Kenney SR, Bailey GL. J Subst Abuse Treat. 2017 Jun;77:67-71. doi: 10.1016/j.jsat.2017.03.002. Abstract https://www.ncbi.nlm…

High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City Mateu-Gelabert, Pedro et al. International Journal of Drug Policy , Volume 46 , 17 - 27 Abstract https://www…

CME. Concurrent Opioid, Benzodiazepine Use Ups Overdose Risk Authors: News Author: Caroline Cassels; CME Author: Charles P. Vega, MD; CME / ABIM MOC / CE Released: 4/26/2017 Valid for credit through: 4/26/2018 http://www.medscape.org/viewartic…

Benzodiazepine absetzen im Alter - Wann und, wenn ja, wie? Dr. Dirk K. Wolter Zeitschrift für Gerontologie und Geriatrie  Ausgabe 2/2017 Abstract https://www.springermedizin.de/der-geriatrische-patient/geriatrie-und-gerontologie/benzod…

The Emergence of New Psychoactive Substance (NPS) Benzodiazepines: A Review. Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. Drug Test Anal. 2017 May 4. doi: 10.1002/dta.2211. Abstract https://www.ncbi.nlm.nih.gov/pubmed/28471096

Flubromazolam - basic pharmacokinetic evaluation of a highly potent designer benzodiazepine. Huppertz LM, Moosmann B, Auwärter V. Drug Test Anal. 2017 Apr 5. doi: 10.1002/dta.2203. Abstract https://www.ncbi.nlm.nih.gov/pubmed/28378533